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In studies initially focused on roles of nonmuscle myosin IIA (NMIIA) in the developing mouse epidermis,
we have discovered that a previously described cytokeratin 5 (K5)-Cre gene construct is expressed in
early embryo development. Mice carrying ﬂoxed alleles of the nonmuscle myosin II heavy chain gene
(NMHC IIAﬂox/ﬂox) were crossed with the K5-Cre line. The progeny of newborn pups did not show a
Mendelian genotype distribution, suggesting embryonic lethality. Analysis of post-implantation
conceptuses from embryonic day (E)9.5 to E13.5 revealed poorly developed embryos and defective
placentas, with signiﬁcantly reduced labyrinth surface area and blood vessel vascularization. These
results suggested the novel possibility that the bovine K5 promoter-driven Cre-recombinase was active
early in trophoblast-lineage cells that give rise to the placenta. To test this possibility, K5-Cre transgenic
mice were crossed with the mT/mG reporter mouse in which activation of GFP expression indicates Cre
transgene expression. We observed activation of K5-Cre-driven GFP expression in the ectoplacental cone,
in the extraembryonic ectoderm, and in trophoblast giant cells in the E6.5 embryo. In addition, we
observed GFP expression at E11.5 to E13.5 in both the labyrinth of the placenta and the yolk sac. NMIIA
expression was detected in these same cell types in normal embryos, as well as in E13.5 yolk sac and
labyrinth. These ﬁndings taken together suggest that NMHC IIA may play critical roles in the early
trophoblast-derived ectoplacental cone and extraembryonic ectoderm, as well as in the yolk sac and
labyrinth tissues that form later. Our ﬁndings are consistent with phenotypes of constitutive NMIIA
knockout mice made earlier, that displayed labyrinth and yolk sac-speciﬁc defects, but our ﬁndings
extend those observations by suggesting possible NMIIA roles in trophoblast lineages as well. These
results furthermore demonstrate that K5-Cre gene constructs, previously reported to be activated
starting at approximately E12.5 in the forming epidermis, may be widely useful as drivers for activation
of cre/lox based gene excision in early embryo extraembronic trophoblast tissues as well.
& 2013 Elsevier Inc. All rights reserved.Introduction
Non-muscle myosin II (NM II) is a major motor protein that
together with actin participates in a plethora of cellular and
developmental processes that require force generation. The NM II
holoenzyme consists of two identical heavy chains and two pairs of
light chains, which in turn can assemble into higher-order bipolar
ﬁlaments that assemble into the cortical cytoskeleton to produce
force (Conti et al., 2004; Conti and Adelstein, 2008; Vicente-
Manzanares et al., 2009). In mammals, three separate genes for
the NMII heavy chains (NMHCs) associate with a common pool ofll rights reserved.light chains to produce isoforms referred to as NM IIA, NM IIB, and
NM IIC (Golomb et al., 2004; Simons et al., 1991).
There have been limited studies addressing roles of NM II in the
epidermis. NM II isoforms are expressed in human epidermal kerati-
nocytes, and activated in vitro in response to wound stimuli (Betapudi
et al., 2010). In Drosophila, NMII is responsible for epidermal dorsal
closure during embryogenesis (Franke et al., 2005), and NM II has
recently been implicated in epidermal barrier function as well
(Sumigray et al., 2012). Our original goal in this work was to examine
the in vivo role of NM IIA during epidermal homeostasis of the skin
using the K5-Cre/LoxP technology, based on the established expression
pattern of the K5 promoter (Blanpain and Fuchs, 2009; Byrne et al.,
1994; Diamond et al., 2000; Gandarillas and Watt, 1995; Jorcano et al.,
1984; Mack et al., 2005; Ramirez et al., 2004). However, our initial
studies revealed that the K5Cre-directed ﬂoxed NM IIA knockout
mutants were embryonic lethal and that this lethality was attributable
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expression throughout the extra-embryonic ectoderm and in the
ectoplacental cone by E6.5. This discovery led to a deeper examination
of embryological phenotypes of the K5Cre-directed ﬂoxed NM IIA
gene disruption.
Although NM IIA and NM IIB are essential during embryogenesis,
their speciﬁc roles are not completely understood. Recent studies
have shown that deletion or mutation of NMHC IIB in mice results in
defects in the brain and heart with eventual death occurring between
embryonic day (E)14.5 and birth (Tullio et al., 1997, 2001). When
NMHC IIA is deleted by germ line ablation, the embryos lack a
visceral endoderm and exhibit cell–cell adhesion defects at E6.5 and
eventually die by E7.5 (Conti et al., 2004; Wang et al., 2011).
Interestingly, when a genetic-replacement strategy is used whereby
NM IIA is replaced by NM IIB via gene-knock-in, or when chimeric
forms of NM IIA (IIA head and IIB tail and vice versa) are knocked-in,
placental defects occur with a failure of vascularization in the
labyrinthine layers (Wang et al., 2010, 2011). Similar placental defects
were also observed in mutant mice that contain a knock-in mutation
(R702C) in the NM IIA motor domain (Zhang et al., 2012). However,
in the NM IIB knock-in mutant mouse line, the placental defects were
characterized not only by a loss of fetal vascularization but a
compacted, smaller labyrinth layer suggesting that this epithelial
compartment which is derived from the trophoblast cell lineage
could possibly be compromised as well.
The placenta is a specialized organ that facilitates the exchange of
nutrients and oxygen between the mother and the fetus (Cross, 2006;
Rossant and Cross, 2001; Watson and Cross, 2005). A key cell type in
the placenta is trophoblast-derived epithelial cells. The trophoblast
layers of the placenta arise from the outer trophectoderm of the
blastocyst (Cross, 2000; Yamanaka et al., 2006). Around the time of
implantation, the trophectoderm next to the inner cell mass (ICM)
continues to proliferate and eventually gives rise to the extraembryo-
nic ectoderm and ectoplacental cone (Simmons and Cross, 2005;
Watson and Cross, 2005). Those trophectoderm cells away from the
ICM differentiate to form the trophoblast giant cells (TGCs) (Coan et al.,
2005; Simmons et al., 2007; Simmons and Cross, 2005). At around
E8.5, chorioallantoic fusion occurs (Cross et al., 2003; Cross, 2006;
Simmons et al., 2008). During this process, the chorion, derived from
the extraembryonic membrane comes into contact with the
mesoderm-derived allantois. Eventually, the trophoblasts in the chor-
ion create folds where blood vessels grow in from the allantois. As
development continues, trophoblasts and the surrounding fetal blood
vessels undergo extensive villous branching to form the highly
specialized compartment known as the labyrinth (Rossant and Cross,
2001). There are a number of placenta-speciﬁc genes that when
disrupted affect the development of the placenta or the cell lineages
that make up the placenta (Hu and Cross, 2011; Rawn and Cross, 2008;
Rossant and Cross, 2001; Watson et al., 2007, 2011).
Our novel ﬁnding regarding the temporal and spatial expres-
sion pattern of the K5 promoter suggests that the placental defects
and early embryonic lethality that we observe are due to the K5-
Cre-directed ablation of the ﬂoxed NMHC IIA gene in the
trophectoderm-derived cells. Therefore, our results suggest an
important role for NM IIA in trophectoderm-derived cells during
placenta development. Furthermore, our results suggest the pos-
sibility that the K5 promoter can be used to excise other ﬂoxed
genes in trophectoderm-derived cells.Materials and methods
Generation of transgenic mouse lines
All mice were housed and bred at the Cleveland Clinic′s Biological
Resource Unit following the institutional guidelines and NationalInstitutes of Health standards. Mice were maintained on a 12-h
light/12-h dark cycle.
To lineage trace expression of the bovine keratin 5 promoter,
keratin 5-Cre (K5Cre) mice (Honda et al., 2007; Ramirez et al.,
2004) were mated with B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,–
EGFP)Luo/J (mT/mG reporter mice; (Muzumdar et al., 2007)). The mT/
mG reporter mouse was kindly provided by Dr. Bruce Trapp.
Homozygous ﬂoxed NMHC II-A mice (II-Aﬂox/ﬂox) have been
described previously (Jacobelli et al., 2010) and are available from
the Mutant Mouse Regional Resource Centers (MMRRC) (#32096).
Mice heterozygous for K5Cre (K5Crehet) and homozygous for
ﬂoxed NMHC IIA (IIAﬂox/ﬂox) were generated as follows: K5Crehet
was crossed to IIAﬂox/ﬂox to generate the bitransgenic, K5Crehet/
IIA(ﬂox/wt). We then crossed K5Crehet/IIA(ﬂox/wt) with IIAﬂox/ﬂox to
generate K5Crehet/IIA(ﬂox/ﬂox) knock-out mice (IIA KO).
Genotyping
Genotyping of embryos and newborn mice was determined by
polymerase chain reaction (PCR). Genomic DNA was isolated from
either the yolk sac of embryos or tails of newborns. The primer
sequences used to identify IIA KO and wild-type alleles of NMIIA
include: the forward primer 5′-GGGACACAGTTGAATCCCTT-3′ and
the reverse primer, 5′-ATGGGCAGGTTCTTATAAGG-3′. The IIA exci-
sion fragment was identiﬁed using the additional reverse primer,
5′-CTCCCTTGACAGGCAGGAGAGCA-3′. Primers (forward primer:
5′-GAACATTCCACAGACCTGCA-3′, reverse primer: 5′-CCTTTGAA
TTGCTGGAACCC-3′) were used for detecting the K5-Cre transgene.
Antibodies
Primary antibodies used in this study include NMIIA (1:250,
Covance), GAPDH (1:1000, Santa Cruz), Actin (1:5000, Sigma),
Keratin 5 (1:1000, Covance), Keratin 10 (1:1000, Covance), Keratin
14 (1:1000, Covance), and alpha-6-integrin (1:1000, BD Pharmin-
gen). The cytokeratin 8 antibody (Troma 1) was obtained from the
Developmental Studies Hybridoma Bank, The University of Iowa,
Department of Biology, Iowa city, IA. Secondary antibodies for
immunoﬂuorescence conjugated to Alexa 488 and Alexa-594 were
purchased from Invitrogen and used at a 1:1000 dilution. Nuclei
were counterstained with DAPI (Vector Lab).
Tissue preparation, histology, and immunoﬂuorescence
Embryos and placentas were harvested at different gestational
ages. E0.5 was deﬁned as noon of the day in which a vaginal plug
was detected. The embryonic tissues were ﬁxed for 1 h at room
temperature in 4% paraformaldehyde in phosphate buffered saline
(PBS). Tissues were then rinsed three times in PBS. For parafﬁn
embedding, tissues were dehydrated, embedded in parafﬁn wax
and the parafﬁn block was cut at room temperature. For OCT
embedded cryosections, tissues were cryoprotected in 30% sucrose
overnight at 4 1C, embedded in OCT (TFM, Electron Microscopy
Sciences, Hatﬁeld, PA) at 4 1C for 1 h, and frozen in cold isopen-
tane. The OCT blocks were stored at 80 1C. Histological sections
were stained with Hematoxylin and Eosin (H and E). For immuno-
ﬂuorescence, the tissue sections were blocked with PBS containing
1% bovine serum albumin, 0.4% TritonX-100, and 0.1% goat serum
for 1 h at room temperature. The primary antibodies were diluted
in PBS, added onto the slides and incubated overnight at 4 1C.
Following three washes in PBS, the slides were incubated with
ﬂuorescence-labeled secondary antibodies for 1 h at room tem-
perature and washed three times. The slides were mounted using
Vectashield mounting medium (Vector Lab, Burlingame Ca) and
analyzed using immunoﬂuorescence microscopy.
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Images were acquired with a Leica SP2 AOBS confocal micro-
scope using an HCX PL APO 63X/1.4N.A. oil immersion objective.Table 1
Genotypic and viability analysis of offspring from K5-Cre/IIAﬂox/+ and IIAﬂox/ﬂox
matings show a non-Mendelian distribution.
Genotype Viable
newborn
at P1
Surviving
newborn
Expected
Mendelian
genotypic
proportions (%)
Observed
genotypic
proportions
(%)
K5-Cre/IIAﬂox/ﬂox 2 0 25 ∼1
K5-Cre/IIAﬂox/+ 46 46 25 32
+/+/IIAﬂox/ﬂox 58 58 25 40
+/+/IIAﬂox/+ 38 38 25 26
Fig. 1. Conditional deletion of NMHC II-A in the epidermis leads to epidermal hyperproli
mouse at postnatal day (P)10 displayed a severely disrupted skin and hair phenotype
stained dorsal skin from P13 reveal a thickened and hyperproliferative epidermis (Epi)
disorganized and disoriented hair follicle growth in the IIA KO compared to control (black
control and IIA KO P13 mice were immunostained for NM IIA (red) and alpha 6-integrin
follicle in the control epidermis. The yellow arrowheads identify representative regions i
The thickened epidermis in the IIA KO is highlighted by the white brackets. Scale bars,
mice and probed with anti-NMIIA antibody and actin which serves as a loading controSome images were also acquired with a Leica DMR wideﬁeld
microscope using an HX PL APO 20X/.7N.A4dry objective.
Western blot analysis
The isolation of the epidermis from mouse skin was prepared
as described (Welter et al., 1995). Protein was extracted from the
mouse epidermis using standard protein extraction methods.
Brieﬂy, the isolated epidermis was diced, placed in Laemmli lysis
buffer (0.0625M Tris HCl, pH 6.8, 2% SDS, 5% β-mercaptoethanol)
and sonicated brieﬂy. Samples were centrifuged at 14,000 g for
10 min at 4 1C. The supernatants were transferred to fresh tubes
and centrifuged an additional 10 min and the supernatants stored
at 20 1C. Epidermal extract (25 μg) was boiled for 4 min and run
in 4–20% SDS-PAGE at 100 v for 1 h and then transferred to
Immobilon-P (Millipore) by semidry transfer (BioRad Laboratories)
at 24 v for 90 min. The membranes were incubated in blockingferation and disruption of hair follicle development in newborn mice (A) The IIA KO
compared to the control littermate (Cntl) (B) Hematoxylin and Eosin ((H) and (E))
in the IIA KO (top panel) compared to the littermate epidermis (bottom panel) and
and yellow arrowheads, respectively). (C) Cryosections from the dorsal skin of both
(green). White arrowheads point to NMIIA localization in the epidermis and hair
n both the epidermis and hair follicles (HF) of the IIA KO that lack NM II expression.
25 μm. (D) Immunoblot analysis of P13 epidermal extracts from control and IIA KO
l.
J. Crish et al. / Developmental Biology 382 (2013) 136–148 139buffer (PBS containing 5% milk) for 2 h and probed overnight at
4 1C with each primary antibody antibody. After three washes in
PBS containing 0.1% Tween, the membranes were incubated with
peroxidase conjugated goat anti-rabbit Ig antibodies (Thermo
Scientiﬁc, Cat No. 32460) for 1 h at room temperature. After
washing, the membranes were incubated with SuperSignal West
Femto Maximum Sensitivity Substrate (Thermo Scientiﬁc) accord-
ing to the manufacturer′s instructions.
For placental and yolk sac western blots, tissue from wild type
C57BL/6 embryos at E12.5 and E14.5 was extracted in RIPA buffer
(Santa Cruz Biotechnology, CA) with additions to give a ﬁnal
concentration of 250 mM NaCl, 5 mM EGTA, 1 mM DTT, 5 mM
ATP, 5 mM MgCl2, 10 μg/ml leupeptin, 0.1 mM PMSF, and 10 μl/ml
Sigma protease inhibitor cocktail. Tissue was homogenized with a
Tissue Tearor (Biospec Products, OK), incubated on ice for 10 min
and centrifuged at 14,000 rpm for 10 min in a refrigerated Eppen-
dorf centrifuge. Pellets from the centrifugation step represent
material enriched for assembled cytoskeletal constituents. These
pellets were resuspended in Laemmli sample buffer with 100 mM
DTT boiled 5 min, centrifuged for 5 min at 14,000 rpm in an
Eppendorf centrifuge. Supernatants were separated by PAGE in
4–12% Tris-glycine gels (Invitrogen, CA). Proteins were transferred
to nitrocellulose, blocked with LiCor Blocking Buffer (Li-Cor, NE) to
which anti-keratin 5 antibody (1:10,000, Covance, CA) or anti-
GAPDH (1:5000, Cell Signaling, MA) was subsequently added for
overnight incubation at 41. Blots were washed, incubated with
ﬂuorescence conjugated anti-mouse or anti-rabbit secondary anti-
body (Li-Cor), washed and ﬂuorescence signal detected with the
Li-Cor Odyssey.Fig. 2. Epidermal homeostasis is disrupted in the P13 skin of IIA KO mice. Skin from con
mouse skin stained for keratin 6 (K6, red) (A), keratin 10 (K10, red) (C), and keratin 14 (K
(red) (F). ((A) to (F)) Control and IIA KO skin sections were also stained for alpha 6 integr
that epidermal hyperproliferation markers (K6 and K14) are elevated and K10, a marke
loading control. Scale bars, 25 μm. Yellow arrowheads in panel (A) denote non-speciﬁcResults
K5-Cre mediated excision of a ﬂoxed NMHC IIA allele results in a
neonatal hyperproliferative epidermis and early postnatal lethality
In experiments designed to address the role of NM IIA in the
developing mouse epidermis, we crossed previously described
mice carrying ﬂoxed alleles of the NMIIA gene (IIAﬂox/ﬂox) (Jacobelli
et al., 2010) to mice carrying Cre-recombinase driven by a bovine
keratin 5 promoter (K5-Cre) to ablate NMHC IIA in basal epithelia.
The original publication of this K5-Cre transgene construct
demonstrated activation in the epidermis of E15.5 embryos, as
expected for a keratin 5 promoter (Ramirez et al., 2004). This
transgene has been widely used to study targeted gene ablation in
the epidermis and in other epithelial tissues such as the basal layer
of the mammary gland duct (Eberl et al., 2012; Ferguson et al.,
2012; Jackson et al., 2011; Omori et al., 2012). We crossed female
IIAﬂox/ﬂox mice with male K5-Cre/IIAﬂox/+ mice to obtain homo-
zygous ﬂoxed mice (K5-Cre/IIAﬂox/ﬂox) which are subsequently
referred to in this study as IIA KO mice. As the K5-Cre transgene
is expressed during oogenesis (Ramirez et al., 2004), all experi-
ments reported in this study are based on introducing the K5-Cre
transgene into embryos via male mice to avoid universal target
gene excision in the fertilized zygote.
Genotype analysis of newborns revealed that offspring from
mating of K5-Cre/IIAﬂox/+ and IIAﬂox/ﬂox mice did not display
Mendelian genotype ratios (Table 1). Instead of the anticipated
25% Mendelian K5-Cre/IIAﬂox/ﬂox genotype (IIA KO), we observed
approximately 1% IIA KO births, represented by 2 live births fromtrol littermate and IIA KO P13 mice was prepared for analysis. ((A), (C), (E)) Control
14, red) (E). ((B), (D), (F)) IIA KO skin stained for K6 (red) (B), K10 (red) (D), and K14
in (green). (G) Western blot analyses of epidermal extracts from IIA KO mice reveal
r of differentiation, is decreased compared to control lysates. Actin is shown as a
staining of the corniﬁed envelope by the secondary antibody.
J. Crish et al. / Developmental Biology 382 (2013) 136–148140two different litters, out of a total of twenty two litters evaluated.
The IIA KO newborns displayed a dramatic skin phenotype and
were sacriﬁced by postnatal day (P) 13 for humane reasons due toFig. 3. Surpabasal Ki67 staining in footpad and back skin of IIA KO mice. Tissues from con
and alpha 6 integrin (green). Yellow arrowheads indicate single basal layer of Ki67 posi
both locations we note that Ki67 staining, while suprabasal in the IIA KO, also displaye
Fig. 4. Epidermal loss of NMHC IIA drives suprabasal integrin ß1 activation. Skin from c
frozen sections. Control mouse skin was stained for activated integrin ß1 and nidogen,
epidermis both activated integrin ß1 (B) and total integrin ß1 (D) display suprabasal local
integrin ß1 in the control epidermis, and the expanded suprabasal expression observe
antibody clone 9EG7 (upper panels) and total integrin ß1 was performed using antibodincreasing loss of any physical activity and lack of feeding or
drinking. The skin of these IIA KO newborns over the ﬁrst week
was increasingly thick and rigid, and exhibited excessive scaling introl littermate and IIA KO P13 mice were ﬁxed, sectioned, and stained for Ki67 (red)
tive cells in control samples and suprabasal Ki67 staining in the IIA KO samples. In
d a weaker signal in all cells. Scale bar, 50 μm.
ontrol littermate and IIA KO P13 mice was analyzed via immunohistochemistry on
a basal lamina marker (A), or for total integrin ß1 and nidogen (C). In the IIA KO
ization. Yellow arrowheads denote single basal layer of the epidermis that expresses
d in the IIA KO epidermis. Staining for activated integrin ß1 was performed using
y clone MB1.2, as previously described (Honda et al., 2007). Scale bar, 50 μm.
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littermate (Fig. 1A). Heterozygous pups (K5-Cre/IIAﬂox/+) did not
display any noticeable phenotype and are referred to as controls in
this study. Histological analysis revealed that the epidermis of IIA
KO newborns was thicker than that of control siblings (Fig. 1B).
Fluorescence immunohistochemistry (Fig. 1C) revealed a loss of
NMIIA expression in the epidermis and outer hair follicle region of
the IIA KO pups (yellow arrows) as compared to the epidermis of
control littermates (white arrows). Hair follicles in the IIA KO
epidermis were irregular in appearance and did not display uni-
form orientation (Fig. 1B and C). In addition, staining intensity of
alpha-6-integrin (Fig. 1C, green) was consistently elevated in the
epidermal and hair follicle basement membrane of the IIA KO
compared to the control. Western blot analysis of protein extracts
from isolated epidermis conﬁrmed the strong reduction in NMIIA
in the epidermis of IIA KO transgenic newborns (Fig. 1D).
The thickened epidermis of IIA KO pups suggested that loss of
NMIIA in the epidermis may interfere with differentiation. To
examine this possibility, immunoﬂuorescence analysis was per-
formed on P13 back skin to examine expression of a series of
epidermal differentiation markers. The keratin proliferative marker,
K6, not normally expressed in the epidermis, was expressed through-
out the IIA KO epidermis (Fig. 2A and B). In addition, K10, which
is normally expressed in the suprabasal region of the epidermisTable 2
Frequency of embryo defects and reabsorption from K5-Cre/IIAﬂox/+ and IIAﬂox/ﬂox
matings (17 l total).
Embryonic
day
Reabsorbed and
defective embryos
Intact
embryos
Total
embryos
% of Embryos
defective (%)
E9.5 12 34 46 26
E10.5 4 30 34 12
E11.5 8 27 35 23
Fig. 5. Embryonic lethality of the IIA KO embryos is underway by E9.5 and is associated w
E9.5, E10.5 and E11.5. By E9.5 many IIA KO embryos show growth retardation and abe
reduced size and less vascularization. Scale bars, 1 cm.appeared to be expressed in the upper layer of the epidermis in the
IIA KO (Fig. 2C and D). In contrast, the expression pattern for K14 was
dramatically altered. The K14 signal is detected in the basal layer of
the control epidermis, but in the IIA KO epidermis, K14 was detected
in the basal and suprabasal region (Fig. 2E and F). Western blot
analysis of epidermal protein extracts from control and IIA KO mice
showed that the hyperproliferative keratin markers (K6 and K14) are
elevated whereas the suprabasal marker (K10) is decreased in the IIA
KO (Fig. 2G). Suprabasal Ki67 staining was observed in epidermis of
IIA KO pups, further demonstrating a hyperproliferative defect in
these mice (Fig. 3). These observations taken together suggest that
ablation of NMIIA in the epidermis results in the loss of epidermal
homeostasis resulting in a hyperproliferative epidermal phenotype.
The mammalian epidermis is renewed from epidermal stem
cells. These stem cells express high levels of active integrin ß1 and
are normally conﬁned to the basal layer of epidermis (Alonso and
Fuchs, 2003; Watt et al., 2006). To determine whether an abnor-
mal differentiation of keratinocytes is linked to the abnormal
distribution of epidermal stem cells, we next examined the
localization of activated integrin ß1 positive cells via immunos-
taining with antibody 9EG7, which recognizes only activated
integrin ß1 (Lenter et al., 1993; Honda et al., 2007). This analysis
showed that integrin ß1-positive cells in the mutant epidermis
were present not only in the basal but also the suprabasal layer
with an increase in number (Fig. 4), suggesting that the loss of
NMIIA might affect differentiation at the level of stem cells in the
interfollicular epidermis.Defective embryo development and placentas in IIA KO mice
The non-Mendelian genotype ratios that we observed for the
newborn mice suggested lethality in the IIA KO embryos. To
further investigate the time when the IIA KO embryos died,
we examined embryos and placentas from crosses betweenith signiﬁcant placental growth retardation. (A) Whole mount views of embryos at
rrant development. (B) Whole mount views of the corresponding placentas reveal
J. Crish et al. / Developmental Biology 382 (2013) 136–148142K5-Cre/IIAﬂox/+ males and IIAﬂox/ﬂox female mice at E9.5, E10.5 and
E11.5. In contrast to the normal embryos, the IIA KO embryos were
markedly reduced in size and were malformed. In some cases the
embryos appeared to have been resorbed (Table 2). Interestingly,
many embryos appeared dead as early as E9.5 (i.e., no detectable
heart beat) suggesting that K5-driven Cre-recombinase activity
occurred very early in embryonic development (Fig. 5A). In addi-
tion, gross morphological examination of the placentas revealed
that the IIA KO placentas were smaller and less developed. More-
over, the IIA KO placentas exhibited a severe loss of vascularization
(Fig. 5B). These results suggest that in most embryos, lethality is
occurring early during development perhaps due in part to defects
in placental development.
Labyrinth and blood vessel development in the IIA KO placenta are
severely reduced
To determine the morphological defects of the IIA KO placenta, we
collected sagittal histological sections of the placenta from crosses
between K5-Cre/IIAﬂox/+ males and IIAﬂox/ﬂox females at E12.5.Fig. 6. Placental defects are observed in the E12.5 IIA KO embryos. DAPI stained nucle
exhibits a labyrinth whose area is dramatically reduced (white line) compared to the cont
labyrinthine layer is thin and in some cases missing in the IIA KO placenta. (H) and (E) sta
a lack of vascular inﬁltration originating from the maternal or fetal side, and a less porous
in (E) and (F), respectively. The green arrowheads in (C) and (E) point to the well dev
arrowheads, panel E) present in the control placenta. This ordered trophoblast cell-vas
yellow arrows highlight a representative region of compacted trophoblast cells presen
control. Scale bars, 25 μm.A representative DAPI gray-scaled image of control placenta reveals
a well-developed labyrinth characterized by a large surface area
(Fig. 6A). In addition, the control trophoblast giant cells (TGCs)
surround the labyrinth in an ordered arrangement. In contrast, the
IIA KO placenta has a poorly developed labyrinth (white line) and a
discontinuous and disorganized layer of TGCs (Fig. 6B). To better
address the morphology of the labyrinth, sagittal placenta sections
were stained with Hematoxylin–Eosin (H and E). The trophoblasts in
the control labyrinth (green arrowheads in Fig. 6C and E) are arranged
in an organized manner associated with fetal blood sinuses. In
addition, an extensive sinus network is observed in the control
labyrinth (Fig. 6C and E, yellow arrowheads). By contrast, the IIA KO
labyrinth (Fig. 6D and F) exhibits tightly packed trophoblast cells
(yellow arrows in Fig. 6F) and a poorly developed labyrinth vascular
network. These data imply that the defects observed in the IIA KO
embryos may be related to defective labyrinth vascularization. This
phenotype is reminiscent of earlier analysis of embryos in which
nonmuscle myosin IIB (NMIIB) was swapped into the NMIIA locus to
force expression of the IIB isoform in place of NMIIA in early
development (Wang et al., 2010). That work demonstrated criticali (gray scale) of control (A) and IIA KO (B) placentas. At E12.5, the IIA KO placenta
rol placenta. The region of trophoblast giant cells (TGC) that normally surrounds the
ining of control (C) and IIA KO (D) placentas reveals that the IIA KO placenta exhibits
network of sinusoidal spaces. The boxed regions in panels (C) and (D) are magniﬁed
eloped and organized trophoblast layer surrounding the vascular sinuses (yellow
cular sinus architecture is absent in the IIA KO placenta (F). Also, in panel (F), the
t throughout the labyrinthine layer of the IIA KO placenta but not evident in the
J. Crish et al. / Developmental Biology 382 (2013) 136–148 143roles for NMIIA in placental vascularization that could not be rescued
by the NMIIB isoform. The observation of placental defects at this early
stage of placental development in the current study was unexpected,
given that the K5-Cre transgene used is widely believed to be
epithelial speciﬁc and to ﬁrst activate in the epidermis at a later stage
of embryogenesis.Fig. 7. K5-Cre:mT/mG transgenic mouse demonstrates temporal- and epithelial-speci
harvested at E10.5, E11.5 and E13.5 days and the embryonic epidermis was isolated an
developing epidermis at E11.5 and universally expressed in the epidermis at E13.5. Whi
indicates boundary between the epidermis and the dermis. Scale bars, 25 μm.
Fig. 8. K5-Cre expression in E6.5 embryos in the ectoplacental cone, extraembryonic
sectioned. H and E stained sections show the decidua (D), ectoplacental cone (EPC), epiblas
(TR). (B) GFP expression in K5-Cre:mT/mG E6.5 embryos. GFP is expressed in the ectoplacCrosses with a double ﬂuorescence reporter mouse demonstrate
K5-Cre expression in trophoblast-derived lineages as early as E6.5
The trophoblast cell disorganization in the IIA KO labyrinth raised
the interesting possibility that the K5 promoter driving Cre recombi-
nase expression is active in trophoblast-lineage derived cells of theﬁc K5-Cre activation in the embryonic epidermis. K5-Cre:mT/mG embryos were
d cryosectioned. GFP expression was ﬁrst detected as patches of expression in the
te arrows indicate the epithelial-speciﬁc expression pattern of GFP, and dotted line
ectoderm and trophectoderm. (A) E6.5 conceptuses were harvested and sagittally
t (EPI), Amniotic cavity (AM C), Amnion (Am), Yolk sac cavity (YC), and trophectoderm
ental cone, extraembryonic ectoderm (EE) and the trophectoderm. Scale bar, 25 μm.
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reported expression in the periderm of E12.5 embryos and the basal
cell layer of the adult epidermis (Ramirez et al., 2004) but earlier
stages were not examined. To address possible earlier expression in
embryos, we utilized a double-ﬂuorescence Cre reporter mouse,
which has a Cre-responsive membrane-delimited Tomato Red ﬂuor-
escence protein (mT)/membrane-delimited Green ﬂuorescence pro-
tein (mG) construct integrated at the ROSA26 locus (mT/mG reporter
mouse). In this mouse, any cells that express Cre recombinase
convert their ﬂuorescence color from red to green (Muzumdar
et al., 2007). We ﬁrst examined K5-Cre transgene activation in the
embryonic epidermis at E10.5, E11.5 and E13.5. Consistent with the
original description of this K5-Cre transgene, we observed GFP
expression in the basal layer of the developing epidermis by E11.5,
and very intense and uniform GFP expression in the basal cells of the
epidermis by E13.5 (Fig. 7). This result is consistent with the temporal
and tissue-speciﬁc expression pattern not only of the original K5-Cre
construct but also with established expression patterns for the
endogenous K5 gene (Byrne et al., 1994). No GFP expression was
detected in the developing dermis of these embryos.
In view of the defects in labyrinth expansion, trophoblast giant
cell distribution, and vascularization in the IIA KO embryos, we
used the mT/mG mouse to examine K5-Cre expression in tropho-
blast lineage-derived cells of the placenta starting at E6.5. K5-Cre:
mT/mG embryos were collected at E6.5 and sagittally sectioned
(Fig. 8A). At this stage, strong GFP expression was seen in cells of
the trophectoderm surrounding the embryo and in cells located in
the ectoplacental cone and extraembryonic ectoderm (Fig. 8B).
GFP expression was never detectable in mT/mG embryos at this
stage (or any other stage) in the absence of the K5-Cre transgene.
These results demonstrate that K5-Cre transgene expression
occurs in trophoblast lineage-derived cells, beginning as early
as E6.5.
We next asked whether endogenous K5 expression occurs in
the E6.5 embryo. Laser scanning confocal immunoﬂuorescence
analysis of E6.5 embryos with an anti-K5 antibody revealed
signiﬁcant immunoreactivity (red) localized to the ectoplacentalFig. 9. Endogenous cytokeratin 5 expression in the E6.5 embryo is observed in the ectop
immunoﬂuorescence microscopy of frozen sections of E6.5 embryos. (A) Sagittal section
with DAPI (blue). The white arrowheads identify K5 signal in the ectoplacental cone (EPC
trophectoderm/decidua (D) border. (B) In the absence of primary antibody against cytokcone and trophectoderm region (Fig. 9A) above the background
signal observed when primary antibody was omitted (Fig. 9B).
These results demonstrate the novel ﬁnding that endogenous K5 is
expressed in trophoblast-derived cells of the developing embryo
as early as E6.5.
K5-Cre is expressed in multiple trophoblastic cell types of the placenta
and yolk sac
To assess K5-Cre activation at later stages of development,
sagittal sections of E10.5, E11.5 and E13.5 placentas were prepared
and examined for activation of the mT/mG reporter expression. The
H and E-stained placentas shown in Fig. 10A and B serve as a guide,
indicating placental locations examined from other sections for
ﬂuorescence. The black boxes in Fig. 10A and B indicate the locations
of the three major cell types examined: spongiotrophoblasts (SPs);
trophoblast giant cells (TGCs); yolk sac (YS). GFP expression indicat-
ing K5-Cre transgene activationwas observed as early as E10.5 in the
spongiotrophoblasts (SP) of the labyrinth (top panels). By E13.5, the
GFP signal was very strong in these cells (Fig. 9A). In the yolk sac,
scattered cells expressed GFP by E11.5, and strong GFP expression
was detected in widespread patches of the yolk sac by E13.5 in K5-
Cre:mT/mG embryos (Fig. 10A). GFP expression was also detected in
the TGCs surrounding the labyrinth at all three times examined
(Fig. 10B). In control analyses, GFP expression was never observed in
these tissues or anywhere else in mT/mG reporter mouse embryos
in the absence of the K5-Cre transgene (not shown). In sum, the
activation of the mT/mG switch to GFP expression in multiple
trophoblast-derived lineages in response to the K5-Cre transgene
suggested that the K5 promoter speciﬁc-deletion of NMHC IIA may
be occurring in early trophoblast lineage-speciﬁc development in
the IIA KO embryos.
The activation of the bovine K5-Cre transgene used in our
studies was not predicted, given the expectation based on many
publications, that endogenous K5 expression should ﬁrst be
observed in embryos in the epidermis, starting around E9.5 to
E10.5 (Byrne et al., 1994; Lu et al., 2005; Ramirez et al., 2004).lacental cone and trophectoderm regions in control embryos. ((A) and (B)) Confocal
of control E6.5 embryo was immunostained for cytokeratin 5 (K5; red) and stained
) and outer trophectoderm layer. The white dots enclose the embryo and denote the
eratin 5 no immunostain signal is detected in the E6.5 embryo. Scale bars, 25 μm.
Fig. 10. K5-Cre-mediated conversion of mT/mG transgene in the developing placenta demonstrates keratin 5 promoter activity in the trophectoderm lineages of TGC and
labyrinthine trophoblasts, and in yolk sac. ((A) and (B)) The panels on the left are representative images of H and E stained placental sections, from E13.5. The boxed areas in
these panels indicate zones that were examined at a higher magniﬁcation by ﬂuorescence in other sections. Top Panels: E10.5, E11.5 and E13.5 placental sections were
examined for GFP expression in the yolk sac (YS) and spongiotrophoblasts (SP) of the labyrinth. Insets for E10.5 and E11.5 show typical yolk sac stains at these time points.
GFP (green), reﬂecting K5-Cre expression, is detected in the yolk sac in many ﬁelds of view at E13.5, in a scattered manner at E11.5, and was not observed in the yolk sac of
E10.5 embryos. In spongiotrophoblasts, GFP was detected in many cells as early as E10.5. Lower panels: E10.5, E11.5 and E13.5 placental sections were also examined for GFP
expression in the trophoblast giant cells (TGC). GFP expression is present by E10.5 and is also evident at the later stages (E11.5, E13.5) The white arrows indicate cells
expressing GFP. Scale bars, 25 μm.
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mine whether endogenous keratin 5 expression could be detected
in early mouse embryos. Although weak, a clear positive signal
above background was detectable in these tissue layers when
control embryos were probed with an anti-keratin 5 antibody,
with a detectable signal in trophoblast cells of the labyrinth and in
the yolk sac (white arrows) (Fig. 11A). As a negative control, no
immunoreactivity was observed when a primary antibody direc-
ted against K10 was examined under identical staining and
imaging conditions (Fig. 11B). While expression of endogenous
K5 was clearly present, this signal was weak as compared to
epidermal expression in the same embryos by E12.5 (Fig. 11C),
possibly explaining why earlier studies did not recognize this
placental expression pattern. Western blot analysis with kertain 5-
directed antibodies further conﬁrmed expression of this protein in
placenta and yolk sac (Fig. 11D). In sum, this analysis demonstrates
that trophoblasts of the labyrinth and yolk sac express K5 but at a
signiﬁcantly lower level relative to K5 expression in the E12.5
epidermis. To our knowledge, this is the ﬁrst report indicating that
K5 is present in trophoblast cells of the labyrinth and yolk sac.
Together, our results demonstrate expression of the K5-Cre trans-
gene not only in the E6.5 trophoblast lineages, but also in the
trophoblast-derived cells of the placenta and yolk sac at later
stages. This work furthermore demonstrates that this expression
parallels expression of endogenous K5 in these same cell types.NMIIA expression is signiﬁcantly decreased in the IIA KO yolk sac at
E12.5
Given the robust GFP signal detected in the E13.5 yolk sac of
the K5-Cre:mT/mG embryos, we examined yolk sacs from the
K5-Cre/ NMHC IIAﬂox/ﬂox embryos for NMIIA expression. In control
yolk sacs, NMIIA is expressed in the cytoplasm and along the
cortical regions of cells (Fig. 12A and B). In contrast, in the IIA KO
yolk sac NMIIA signal was signiﬁcantly reduced (Fig. 12C and D).
The endothelial cells in both the control and IIA KO yolk sacs show
a strong immunoreactive signal to the NMIIA antibody. Although
these results indicate that K5-directed deletion of NMHC IIA
occurs in the IIA KO yolk sac by E13.5, signiﬁcant defects in
development are detected as early as E9.5 (Fig. 5). Although
limited tissue amounts precluded genotyping to directly assess
developmental consequences of NMIIA deletion at E6.5, the
observation of mT/mG conversion by E6.5 suggests that loss of
NMIIA in trophoblastic tissue from days E6.5 to E9.5 may be the
primary driving problem leading to lethality in IIA KO embryos.Discussion
In studies initially focused on the role of NM IIA in the mouse
epidermis, we have discovered that a widely used keratin 5-Cre
Fig. 11. Endogenous cytokeratin 5 (K5) is detected in the labyrinthine layer and yolk sac of control E12.5 placentas. (A) The labyrinthine layer and yolk sac epithelia are
derived from the trophectoderm and primitive endoderm, respectively. Wide ﬁeld conventional immunoﬂuorescence microscopy of frozen tissue sections of the E12.5
placenta revealed that the labyrinthine layer and yolk sac express endogenous K5, a basal cell marker. White arrows denote K5 expression in the labyrinthine layer and yolk
sac. Blue is nuclear DAPI stain. (B) In contrast, no immunoﬂuorescent signal is detected in the labyrinthine layer or yolk sac with an antibody against cytokeratin 10, a
suprabasal marker. (C) Immunoﬂuorescence staining of frozen cross section of E12.5 embryonic epidermis with a anti-cytokeratin 5 antibody (green). Scale bars, 25 μm.
(D) Western blot of placenta (Pl) and yolk sac (YS) lysates at E12.5 and E14.5. Ear tissue lysate was used as a positive control for K5 expression. The lower portion of the same
ﬁlter was probed for GAPDH as a loading control.
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trophectoderm-derived epithelial cells and in epithelial cells
derived from the extraembryonic endoderm. Mouse conceptuses
at the early blastocyst stage (E4.5) develop into three distinct
lineages: ﬁrst, the trophectoderm (polar and mural), second, the
inner cell mass (ICM) that will eventually give rise to the devel-
oping embryo, and third, the primitive endoderm responsible for
the development of the parietal and visceral endoderm. ICM
lineages thus give rise to essentially all embryonic cell types, and
contribute to extraembryonic tissues such as the placenta and yolk
sac. The trophectoderm contributes to most of the extraembryonic
cells, including giant cells, the ectoplacental cone, and the extra-
embryonic ectoderm (Cross, 2000, 2006; Cross et al., 2003; Senner
and Hemberger, 2010; Yamanaka et al., 2006). It is this trophecto-
derm derived component in combination with the allantoic
mesoderm of the embryo that eventually gives rise to the
labyrinthine layer, a complex structure of intertwined blood
vessels and sinuses that mediates nutrient transfer from the
maternal side to the embryo. The original report of global NM
IIA disruption in mouse embryos revealed a clear and intriguing
defect in the formation of the ICM-derived visceral endoderm (VE)
by E6.5. In NM IIA / embryos, this epithelial layer, normally
well-organized with basal/apical polarity, was poorly organized(Conti et al., 2004). Subsequent differentiation of the VE was
defective, indicated by lack of expression of a series of markers
such as apo-AI, apo-B, α-fetoprotein, and retinal-binding protein.
In subsequent studies by Wang and colleagues, a NM IIB cDNA
was knocked-in to the NMHC IIA locus, to ask whether essential
roles of NM IIA at E6.5 could be complemented by the NM IIB
isoform. Knock-in embryos in fact were rescued at this stage,
evidenced by restoration of polarized VE at E6.5 with uniform
E-cadherin junctions (Wang et al., 2010). However, these embryos
failed at E9.5 to E12.5, with defects in placental development that
included failed angiogenesis throughout the embryo and failed
development and expansion of the labyrinthine layer. This analysis
demonstrated an isoform-speciﬁc requirement for NM IIA in
placental function and global angiogenesis throughout the
embryo. Our unexpected targeting of NM IIA disruption in early
embryo trophoblast lineages has led to a phenotype reminiscent of
that of Wang and colleagues. Notably, we did not observe defects
in organization of the visceral endoderm, but we did observe that
the IIA KO placentas have an underdeveloped labyrinth in addition
to a lack of fetal blood spaces and maternal blood sinuses. Our
results substantiate the earlier results and importantly, further
argue that NM IIA has critical roles in the trophoblast lineages
during these processes as our K5-Cre conditional knockout
Fig. 12. IIA KO mice exhibit diminished NMIIA expression along the cortical cell region of the yolk sac epithelium. Immunoﬂuorescence staining of sections from the yolk sac
of control ((A),(B)) and IIA KO ((C),(D)) embryos at E12.5 using antibody that detects NMIIA (green), with DAPI stain for nuclei (blue). White arrows indicate cortical staining
of NMHC II-A in the epithelial cells of the control yolk sac (panels (A) and (B)), and diminished staining in IIA KO (panels (C) and (D)). Scale bars, 25 μm.
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development.
The bovine keratin 5-Cre transgene used in our work has been
used in a number of earlier conditional gene disruption studies
targeting the epidermis (Chrostek et al., 2006; Essayem et al.,
2006; Grose et al., 2007; Jackson et al., 2011; Omori et al., 2006,
2012). Most of these publications were either silent regarding any
observations of embryonic lethality, or in a few cases commented
that pups were born at normal Mendelian ratios. One report,
focused on mammary gland disruption of the tumor suppressor
Wwox did report unexplained premature lethality in males and
females that was independent of mammary gland development
(Ferguson et al., 2012), possibly consistent with unrecognized
K5-Cre expression at an earlier stage of development. We spec-
ulate that the lack of early embryonic defects in most published
studies further reﬂects the critical and non-redundant roles of NM
IIA in extraembryonic development, relative to other target genes
that have been excised with this Cre transgene.
The limited number of live births we obtained from
K5-Cre IIAﬂox/ﬂox crosses (two) limits our ability to draw conclusions
regarding the role of NM IIA in epidermal development. However, it is
intriguing that both pups displayed hyperproliferative skin and
defective hair follicle formation. These phenotypes are reminiscent
of earlier studies where cell–cell junction constituents have been
subjected to epidermal-restricted knockout. For example, epidermal
disruption of the adherens junction protein α-catenin leads to epider-
mal disorganization, hyperproliferation, epidermal thickening, as well
as defects in stratiﬁcation (Vasioukhin et al., 2001a, 2001b). Disruptionof p120-catenin, another key adherens junction regulatory protein,
similarly leads to epidermal hyperplasia and inappropriate suprabasal
expression of keratin 6 (Perez-Moreno et al., 2006). We speculate that
NM IIA may be a critical mediator of cell–cell junction formation in the
epidermis, and its disruption results in barrier dysfunction and
inﬂammation for similar reasons as in the earlier studies. Future
studies, relying on tamoxifen-inducible Cre constructs (Indra et al.,
1999), will likely be needed to address this hypothesis in depth.
In conclusion, these results extend previously reported trans-
genic ﬁndings demonstrating that NM IIA has an important role in
placental development (Wang et al., 2010; Zhang et al., 2012), by
demonstrating essential roles for NM IIA in extraembryonic
lineages. It will be of interest in future studies to determine why
NM IIA is critical in trophectoderm lineages. In the original NM IIA
disruption (Conti et al., 2004), it was established that NM IIA had a
critical role in stabilizing E-cadherin cell–cell junctions, a role that
could be rescued with forced NM IIB expression (Wang et al.,
2010). Conceivably NM IIA plays a similar role in trophectoderm
and extraembryonic endoderm of the placenta and yolk sac,
respectively, during labyrinth and yolk sac formation.Acknowledgements
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